ArticleJAAD case reports2026

Topical ruxolitinib for prebullous phase of immune checkpoint Inhibitor-Induced bullous pemphigoid.

Ines Lederbogen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.